10-QPeriod: Q2 FY2024

COHERENT CORP. Quarterly Report for Q2 Ended Dec 31, 2023

Filed February 6, 2024For Securities:COHR

Summary

Coherent Corp. reported a net loss of $28.5 million for the three months ended December 31, 2023, an improvement from a net loss of $45.1 million in the prior year period. This improvement was driven by a significant decrease in revenues, down 17% year-over-year to $1.13 billion, across all key markets, including Networking, Materials, and Lasers. While gross margin percentage improved slightly due to favorable adjustments related to the prior acquisition, underlying operational challenges such as lower revenues, underutilized capacity, and higher costs impacted profitability. The company also saw a notable increase in cash and cash equivalents, largely due to a $1 billion investment in its Silicon Carbide subsidiary from Denso Corporation and Mitsubishi Electric Corporation, which strengthens the company's financial flexibility. Despite the revenue decline, the company continues to invest in research and development, albeit at a slightly reduced pace. Significant restructuring and synergy initiatives are underway, aimed at improving efficiency and cost structure, with expected completion by fiscal year 2025. Coherent's liquidity remains strong, supported by its cash position and available borrowing capacity, positioning it to manage its working capital and capital expenditure needs. Investors should monitor the impact of ongoing restructuring and the recovery in demand across its end markets.

Financial Statements
Beta

Key Highlights

  • 1Net loss narrowed to $28.5 million in Q3 FY24 from $45.1 million in Q3 FY23, despite a 17% decrease in revenue.
  • 2Total revenues declined 17% year-over-year to $1.13 billion for the three months ended December 31, 2023, impacted by reduced demand across all market segments.
  • 3A significant $1 billion investment was received from Denso Corporation and Mitsubishi Electric Corporation into the Silicon Carbide LLC subsidiary, boosting cash reserves and financial flexibility.
  • 4Gross margin percentage saw a slight improvement to 31% from 30%, partly due to favorable acquisition-related adjustments, but underlying margins were pressured.
  • 5Operating expenses, including R&D and SG&A, decreased year-over-year as a percentage of revenue, driven by cost control and restructuring efforts.
  • 6The company continues to execute restructuring and site consolidation plans, expected to be substantially completed by the end of fiscal year 2025.
  • 7Cash and cash equivalents significantly increased to $856.3 million as of December 31, 2023, from $821.3 million at June 30, 2023, bolstered by the Silicon Carbide investment.

Frequently Asked Questions

Coherent Corp. reported a net loss of $28.5 million for the three months ended December 31, 2023, which is an improvement compared to a net loss of $45.1 million in the same period last year. However, revenues decreased by 17% year-over-year to $1.13 billion, reflecting a challenging demand environment across its key markets.

The company received a $1 billion investment from Denso Corporation and Mitsubishi Electric Corporation into its Silicon Carbide LLC subsidiary. This significantly increased Coherent's cash and cash equivalents and provided greater financial and operational flexibility, with the funds earmarked for future capital expansion of the Silicon Carbide business.

Coherent is implementing significant restructuring and synergy plans, which are expected to be substantially completed by the end of fiscal year 2025. These initiatives aim to streamline operations, reduce costs, and improve efficiency. The company has also seen a decrease in operating expenses as a percentage of revenue, reflecting these cost control efforts.

Key concerns include the continued decline in revenues across major segments, potential headwinds from underutilized operating capacity, and the impact of ongoing restructuring on short-term operational performance. The report also notes that goodwill in the Lasers reporting unit could be at risk for impairment if performance does not meet expectations.